Mar 09, 2026 (MarketLine via COMTEX) --
Ono Pharmaceutical Co., Ltd. announced it was selected as a 2026 Health and Productivity Stock by the Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange.
This selection marks the third time in two years since FY2024. This time, 44 companies from 28 industries were selected out of 3,765 that participated in the Survey on Health and Productivity Management.
Ono was also recognized by the METI and the Nippon Kenko Kaigi as a "2026 Certified Health & Productivity Management Outstanding Organization (White 500 / Large Enterprise Category)" for the eighth consecutive year.
Under the corporate philosophy "Dedicated to the Fight against Disease and Pain", Ono aim to contribute to society through the creation of innovative medicines. To continue our challenge in realizing this philosophy, we believe it is essential to foster a healthy and secure working environment for our group employees, both physically and mentally, as well as to ensure the well-being of their families. For this reason, we are actively engaged in health and productivity management initiatives.
As part of our efforts to expand human capital, we are working to raise health awareness among employees by setting a target to reduce the gap between employees' "health age*" and their actual age by 3.0 years. Since 2009, we have held an annual "Walking Campaign", and starting in 2024, we have implemented social contribution activities to support patients and their families based on the total number of participants and steps taken during the Walking Campaign. Through these health initiatives, we foster a culture where employees take the initiative in maintaining and improving their health, and we are committed to creating a workplace environment where each employee can fully demonstrate their abilities and individuality.
*: "Health Age" is a registered trademark of JMDC Ltd.
Ono will continue to deepen its commitment to health management, aiming for sustainable corporate growth and further contributions to society.
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
COMTEX_478962924/2227/2026-05-11T22:45:49
Copyright (C) 2026 Datamonitor. All rights reserved
